Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, Bo Martin Bibby, Hendrik Vilstrup, Jacob George, Henning Grønbæk – 13 March 2014 – Macrophages are involved in inflammation and liver fibrosis and soluble (s)CD163 is a specific marker of activated macrophages. We investigated associations between sCD163 and biochemical and histological parameters of inflammatory activity and fibrosis in 551 patients with chronic hepatitis C virus (HCV) and 203 patients with chronic hepatitis B virus (HBV) before antiviral treatment.

Rajeshwar Mookerjee, Gautam Mehta, Rajiv Jalan – 13 March 2014

James E. Everhart, Constance E. Ruhl – 13 March 2014

Pan Zhao, Zhenman Wei, Wanshu Liu – 13 March 2014

Sara Montagnese, Sami Schiff, Piero Amodio – 13 March 2014

Michael J. Englesbe, Amit K. Mathur, Seth A. Waits, John C. Magee – 12 March 2014

Dong‐liang Chen, Zhi‐qiang Wang, Zhao‐lei Zeng, Wen‐jing Wu, Dong‐sheng Zhang, Hui‐yan Luo, Feng Wang, Miao‐zhen Qiu, De‐shen Wang, Chao Ren, Feng‐hua Wang, Lucia J. Chiao, Helene Pelicano, Peng Huang, Yu‐hong Li, Rui‐hua Xu – 11 March 2014 – The purpose of this study was to identify microRNAs (miRNAs) involved in the pathology of colorectal cancer (CRC) liver metastasis and investigate their underlying mechanisms.

Ping‐Hsien Chen, Ming‐Chih Hou – 11 March 2014

Yuxia Zhang, Ningyi Xu, Jun Xu, Bo Kong, Bryan Copple, Grace L. Guo, Li Wang – 11 March 2014 – E2F transcription factor 1 (E2F1) is an important regulator of metabolic diseases; however, its role in liver function remains elusive. This study unraveled a regulatory cascade involving E2F1, early growth response‐1 (Egr‐1), nuclear receptor small heterodimer partner (SHP, NR0B2), and EIA‐like inhibitor of differentiation 1 (EID1) in cholestatic liver fibrosis.

Robert C. Huebert, Vijay H. Shah – 11 March 2014